Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention
暂无分享,去创建一个
[1] Antibiotic resistance threats in the United States, 2019 , 2019 .
[2] J. Weiser,et al. Streptococcus pneumoniae: transmission, colonization and invasion , 2018, Nature Reviews Microbiology.
[3] T. Kilpi,et al. Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial. , 2018, Vaccine.
[4] M. Khan,et al. Molecular Characterization of Pneumococcal Surface Protein A (PspA), Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Isolated from Pakistan , 2018, Infectious Diseases and Therapy.
[5] A. Choi,et al. NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[6] Xinyuan Zhang,et al. Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection , 2018, Front. Immunol..
[7] Douglas I. Johnson. Bacterial Pathogens and Their Virulence Factors , 2017, Springer International Publishing.
[8] P. Sly,et al. Streptococcus pneumoniae colonization of the nasopharynx is associated with increased severity during respiratory syncytial virus infection in young children , 2017, Respirology.
[9] K. Mulholland. Problems with the WHO guidelines for management of childhood pneumonia. , 2018, The Lancet. Global health.
[10] Joon Beom Seo,et al. Development of a Computer-Aided Differential Diagnosis System to Distinguish Between Usual Interstitial Pneumonia and Non-specific Interstitial Pneumonia Using Texture- and Shape-Based Hierarchical Classifiers on HRCT Images , 2018, Journal of Digital Imaging.
[11] Eyal Oren,et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.
[12] Vincenzo Carnevale,et al. Assessment of thoracic ultrasound in complementary diagnosis and in follow up of community-acquired pneumonia (cap) , 2017, BMC Medical Imaging.
[13] K. O'Brien,et al. Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities , 2017, Epidemiology and Infection.
[14] P. Schmieder,et al. Structure of the competence pilus major pilin ComGC in Streptococcus pneumoniae , 2017, The Journal of Biological Chemistry.
[15] H. Tettelin,et al. Transcriptional organization of pneumococcal psrP-secY2A2 and impact of GtfA and GtfB deletion on PsrP-associated virulence properties. , 2017, Microbes and infection.
[16] O. Fufezan,et al. Performance of lung ultrasonography for the diagnosis of communityacquired pneumonia in hospitalized children. , 2017, Medical ultrasonography.
[17] A. Gervaix,et al. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR , 2017, European Journal of Pediatrics.
[18] M. Epstein,et al. Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications , 2017, American journal of therapeutics.
[19] S. Bergmann,et al. Impact of Streptococcal Enolase in Virulence , 2017 .
[20] W. Edmunds,et al. Identifying human encounters that shape the transmission of Streptococcus pneumoniae and other acute respiratory infections , 2018, Epidemics.
[21] E. Shapiro,et al. Developing Better Pneumococcal Vaccines for Adults , 2017, JAMA internal medicine.
[22] K. Ariyoshi,et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. , 2017, The Lancet. Infectious diseases.
[23] D. Musher,et al. White Blood Cell Counts, Alcoholism, and Cirrhosis in Pneumococcal Pneumonia , 2017, Open forum infectious diseases.
[24] E. Eisenmesser,et al. Streptococcus pneumoniae IgA1 protease: A metalloprotease that can catalyze in a split manner in vitro , 2017, Protein science : a publication of the Protein Society.
[25] David Goldblatt,et al. Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration , 2017, bioRxiv.
[26] Qing‐Yu He,et al. Crucial residue Trp158 of lipoprotein PiaA stabilizes the ferrichrome-PiaA complex in Streptococcus pneumoniae. , 2017, Journal of inorganic biochemistry.
[27] Jeremy Anderson,et al. The contrasting roles of Th17 immunity in human health and disease , 2017, Microbiology and immunology.
[28] J. Weiser,et al. Host-to-Host Transmission of Streptococcus pneumoniae Is Driven by Its Inflammatory Toxin, Pneumolysin. , 2017, Cell host & microbe.
[29] Ling Long,et al. Lung ultrasound for the diagnosis of pneumonia in adults , 2017, Medicine.
[30] L. Bakaletz. Viral–bacterial co-infections in the respiratory tract , 2016, Current Opinion in Microbiology.
[31] P. Royle,et al. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis. , 2017, The Lancet. Global health.
[32] H. Mikamo,et al. Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review , 2017, BMC Research Notes.
[33] H. Endtz,et al. Viral and bacterial co-infection in severe pneumonia triggers innate immune responses and specifically enhances IP-10: a translational study , 2016, Scientific Reports.
[34] M. Pichichero,et al. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection , 2016, Infection and Immunity.
[35] Franziska Voß,et al. Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion , 2016, FEBS letters.
[36] D. Olson,et al. Use of PCV13 and PPSV23 in Adult Population: Are We Following the Advisory Committee on Immunization Practices Recommendations? , 2016 .
[37] V. Appay,et al. Aging of the immune system: Focus on inflammation and vaccination , 2016, European journal of immunology.
[38] K. Bennett,et al. Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial , 2016, Scientific Reports.
[39] Ronald Anderson,et al. Epidemiology, virulence factors and management of the pneumococcus , 2016, F1000Research.
[40] Li-Min Huang,et al. Is Pneumococcal Serotype Replacement Impending? , 2016, Pediatrics and neonatology.
[41] A. Shaw,et al. Host Resistance and Immune Aging. , 2016, Clinics in geriatric medicine.
[42] E. Klein,et al. The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis , 2016, Influenza and other respiratory viruses.
[43] C. D. Dela Cruz,et al. Pneumococcal Vaccination Strategies. An Update and Perspective. , 2016, Annals of the American Thoracic Society.
[44] B. Maestro,et al. Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials , 2016, Antibiotics.
[45] Haley R Pipkins,et al. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media , 2016, Front. Cell. Infect. Microbiol..
[46] L. McGee,et al. Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective , 2016, Clinical Microbiology Reviews.
[47] J. Kwang,et al. Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest , 2016, Scientific Reports.
[48] Harvard Medical School,et al. Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis , 2016, mBio.
[49] L. Ostrowski,et al. Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[50] Chasity M. Shelton,et al. A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens. , 2016, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
[51] E. Tuomanen,et al. Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium , 2016, Nature Communications.
[52] Qing-Yu He,et al. Integrated Translatomics with Proteomics to Identify Novel Iron–Transporting Proteins in Streptococcus pneumoniae , 2016, Front. Microbiol..
[53] R. Malley,et al. Rationale and prospects for novel pneumococcal vaccines , 2016, Human vaccines & immunotherapeutics.
[54] D. Briles,et al. Pneumolysin plays a key role at the initial step of establishing pneumococcal nasal colonization , 2016, Folia Microbiologica.
[55] Julie G. Burel,et al. Systems Approaches towards Molecular Profiling of Human Immunity. , 2016, Trends in immunology.
[56] N. Suttorp,et al. Inflammasomes in Pneumococcal Infection: Innate Immune Sensing and Bacterial Evasion Strategies. , 2016, Current topics in microbiology and immunology.
[57] J. Lord,et al. Immune ageing and susceptibility to Streptococcus pneumoniae , 2015, Biogerontology.
[58] A. McMichael,et al. Evolution of the immune system in humans from infancy to old age , 2015, Proceedings of the Royal Society B: Biological Sciences.
[59] L. Leite,et al. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing. , 2015, Microbial pathogenesis.
[60] B. Kobe,et al. Characterizing the conformational dynamics of metal-free PsaA using molecular dynamics simulations and electron paramagnetic resonance spectroscopy. , 2015, Biophysical chemistry.
[61] M. Kollef,et al. Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults , 2015, Medicine.
[62] Rianne Fijten,et al. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia , 2015, Scientific Reports.
[63] T. Pilishvili,et al. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. , 2015, Vaccine.
[64] Ernesto García,et al. In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes. , 2015, Environmental microbiology reports.
[65] J. Crapo,et al. Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study , 2015, Respiratory Research.
[66] C. Whitney,et al. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2015, MMWR. Morbidity and mortality weekly report.
[67] Md. Arif Sheikh,et al. The Crystal Structure of Pneumolysin at 2.0 Å Resolution Reveals the Molecular Packing of the Pre-pore Complex , 2015, Scientific Reports.
[68] Melonie P. Heron. Deaths: Leading Causes for 2012. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[69] J. Kilby,et al. Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection. , 2015, Vaccine.
[70] M. Ohnishi,et al. Capsule Switching and Antimicrobial Resistance Acquired during Repeated Streptococcus pneumoniae Pneumonia Episodes , 2015, Journal of Clinical Microbiology.
[71] F. Blasi,et al. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease , 2015, Thorax.
[72] J. Koeck,et al. Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines , 2015, PloS one.
[73] D. Su,et al. Thymic involution beyond T-cell insufficiency , 2015, Oncotarget.
[74] S. Tan,et al. Alexander Fleming (1881-1955): Discoverer of penicillin. , 2015, Singapore medical journal.
[75] M. Nahm,et al. Pneumococcal Capsules and Their Types: Past, Present, and Future , 2015, Clinical Microbiology Reviews.
[76] J. Kwang,et al. Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells , 2015, Proceedings of the National Academy of Sciences.
[77] J. Stek,et al. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. , 2015, Vaccine.
[78] J. McCullers,et al. Mechanisms of Predisposition to Pneumonia , 2015 .
[79] T. Vernet,et al. Streptococcus pneumoniae GAPDH Is Released by Cell Lysis and Interacts with Peptidoglycan , 2015, PloS one.
[80] D. Grobbee,et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. , 2015, The New England journal of medicine.
[81] Jamie K. Lemon,et al. Degradation Products of the Extracellular Pathogen Streptococcus pneumoniae Access the Cytosol via Its Pore-Forming Toxin , 2015, mBio.
[82] S. Hammerschmidt,et al. Pneumococcal hydrogen peroxide-induced stress signaling regulates inflammatory genes. , 2015, The Journal of infectious diseases.
[83] A. Hakansson,et al. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease , 2015, Front. Cell. Infect. Microbiol..
[84] N. Høiby,et al. Strategies for combating bacterial biofilm infections , 2014, International Journal of Oral Science.
[85] R. Wilson,et al. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses , 2014, Mucosal Immunology.
[86] Aldert L. Zomer,et al. Non-Adhesive Surface Proteins of Streptococcus pneumoniae , 2015 .
[87] K. Peters,et al. The Pneumococcal Cell Wall , 2015 .
[88] Jeremy S. Brown,et al. Streptococcus pneumoniae Interactions with Macrophages and Mechanisms of Immune Evasion , 2015 .
[89] W. Swords,et al. Pneumococcal Biofilms and Bacterial Persistence During Otitis Media Infections , 2015 .
[90] J. Hermoso,et al. Structure and Function of Choline-Binding Proteins , 2015 .
[91] L. McGee,et al. Antibiotic Resistance of Pneumococci , 2015 .
[92] H. Tettelin,et al. Genomics, Genetic Variation, and Regions of Differences , 2015 .
[93] A. Kadioglu,et al. Chapter 14 – Pneumolysin , 2015 .
[94] L. Cauley,et al. Why is coinfection with influenza virus and bacteria so difficult to control? , 2015, Discovery medicine.
[95] M. Pichichero,et al. The host immune dynamics of pneumococcal colonization: Implications for novel vaccine development , 2014, Human vaccines & immunotherapeutics.
[96] B. Kroesen,et al. Aging disturbs the balance between effector and regulatory CD4+ T cells , 2014, Experimental Gerontology.
[97] F. Sánchez‐Madrid,et al. Pleiotropic Effects of Cell Wall Amidase LytA on Streptococcus pneumoniae Sensitivity to the Host Immune Response , 2014, Infection and Immunity.
[98] Hong Wang,et al. Mucosal Immunization with the Live Attenuated Vaccine SPY1 Induces Humoral and Th2-Th17-Regulatory T Cell Cellular Immunity and Protects against Pneumococcal Infection , 2014, Infection and Immunity.
[99] K. L. Nawrocki,et al. Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria , 2014, Antibiotics.
[100] A. Descoteaux,et al. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases , 2014, Front. Immunol..
[101] Umed Ajani,et al. Summary of notifiable diseases--United States, 2012. , 2014, MMWR. Morbidity and mortality weekly report.
[102] C. Whitney,et al. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2014, MMWR. Morbidity and mortality weekly report.
[103] P. Skipp,et al. Pronounced Metabolic Changes in Adaptation to Biofilm Growth by Streptococcus pneumoniae , 2014, PloS one.
[104] N. Andrews,et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. , 2014, The Lancet. Infectious diseases.
[105] Qing‐Yu He,et al. Chemical Interference with Iron Transport Systems to Suppress Bacterial Growth of Streptococcus pneumoniae , 2014, PloS one.
[106] J. Casanova,et al. TLR-Mediated Inflammatory Responses to Streptococcus pneumoniae Are Highly Dependent on Surface Expression of Bacterial Lipoproteins , 2014, The Journal of Immunology.
[107] R. Adegbola,et al. Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis , 2014, PloS one.
[108] J. Yagüe,et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response , 2014, Nature Immunology.
[109] P. Polgreen,et al. Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers. , 2014, Diagnostic microbiology and infectious disease.
[110] S. Siegel,et al. TLR2 Signaling Decreases Transmission of Streptococcus pneumoniae by Limiting Bacterial Shedding in an Infant Mouse Influenza A Co-infection Model , 2014, PLoS pathogens.
[111] Cong-Zhao Zhou,et al. Structure of Pneumococcal Peptidoglycan Hydrolase LytB Reveals Insights into the Bacterial Cell Wall Remodeling and Pathogenesis* , 2014, The Journal of Biological Chemistry.
[112] M. A. Chavez,et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis , 2014, Respiratory Research.
[113] M. Kirschfink,et al. Complement Profile in Neonates of Different Gestational Ages , 2014, Scandinavian journal of immunology.
[114] Lucia H. Lee,et al. Towards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention , 2014, Vaccines.
[115] D. Svergun,et al. Structural and Functional Insights into Peptidoglycan Access for the Lytic Amidase LytA of Streptococcus pneumoniae , 2014, mBio.
[116] Richard G. Wunderink,et al. Clinical practice. Community-acquired pneumonia. , 2014, The New England journal of medicine.
[117] A. Simonetti,et al. Management of community-acquired pneumonia in older adults , 2014, Therapeutic advances in infectious disease.
[118] Thomas Geeraerts,et al. Performance comparison of lung ultrasound and chest x-ray for the diagnosis of pneumonia in the ED. , 2014, The American journal of emergency medicine.
[119] K. O'Brien,et al. Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use , 2014, PloS one.
[120] R. Stockley,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly : toward targeted treatments for immunosenescence , 2013 .
[121] C. Castelo-Branco,et al. The immune system and aging: a review , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[122] J. Rubins,et al. Pneumococcal IgA1 Protease Subverts Specific Protection By Human IgA1 , 2013, Mucosal Immunology.
[123] H. Ovens,et al. Community-acquired pneumonia. , 2014, The New England journal of medicine.
[124] J. Whitsett,et al. Respiratory epithelial cells orchestrate pulmonary innate immunity , 2014, Nature Immunology.
[125] A. Hakansson,et al. Biofilm Formation Enhances Fomite Survival of Streptococcus pneumoniae and Streptococcus pyogenes , 2013, Infection and Immunity.
[126] Charles Feldman,et al. Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease , 2013, Mediators of inflammation.
[127] J. Rosch,et al. The roles of transition metals in the physiology and pathogenesis of Streptococcus pneumoniae , 2013, Front. Cell. Infect. Microbiol..
[128] M. Nahm,et al. Diagnosis of Pneumococcal Pneumonia: Current Pitfalls and the Way Forward , 2013, Infection & chemotherapy.
[129] A. Jansen,et al. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA. , 2013, Vaccine.
[130] M. Hackel,et al. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. , 2013, Vaccine.
[131] Robert E W Hancock,et al. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. , 2013, Current opinion in microbiology.
[132] M. Lipsitch,et al. Surface Charge of Streptococcus pneumoniae Predicts Serotype Distribution , 2013, Infection and Immunity.
[133] H. Yi,et al. Novel Role for the Streptococcus pneumoniae Toxin Pneumolysin in the Assembly of Biofilms , 2013, mBio.
[134] Yuxing Chen,et al. Structures of Streptococcus pneumoniae PiaA and Its Complex with Ferrichrome Reveal Insights into the Substrate Binding and Release of High Affinity Iron Transporters , 2013, PloS one.
[135] C. Whitney,et al. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2013, MMWR. Morbidity and mortality weekly report.
[136] G. Giudice,et al. Expression of the Streptococcus pneumoniae pilus-1 undergoes on and off switching during colonization in mice , 2013, Scientific Reports.
[137] E. Le Cam,et al. A Type IV Pilus Mediates DNA Binding during Natural Transformation in Streptococcus pneumoniae , 2013, PLoS pathogens.
[138] P. Andrew,et al. Streptococcus pneumoniae and reactive oxygen species: an unusual approach to living with radicals. , 2013, Trends in microbiology.
[139] P. Gibson,et al. Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD , 2013, Mediators of inflammation.
[140] M. Fliegauf,et al. Mucociliary Clearance Defects in a Murine In Vitro Model of Pneumococcal Airway Infection , 2013, PloS one.
[141] P. Kubes,et al. Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.
[142] D. Frommhold,et al. Neutrophil and endothelial adhesive function during human fetal ontogeny , 2013, Journal of leukocyte biology.
[143] S. Gurunathan,et al. Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults. , 2013, Vaccine.
[144] N. Warner,et al. MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction , 2013, The Journal of Immunology.
[145] J. Parkhill,et al. Pneumococcal Capsular Switching: A Historical Perspective , 2012, The Journal of infectious diseases.
[146] D. Golenbock,et al. Defective pro-IL-1β responses in macrophages from aged mice , 2012, Immunity & Ageing.
[147] R. Andrews,et al. Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction. , 2012, Blood reviews.
[148] D. Rhee,et al. Pneumococcal Surface Protein A Inhibits Complement Deposition on the Pneumococcal Surface by Competing with the Binding of C-Reactive Protein to Cell-Surface Phosphocholine , 2012, The Journal of Immunology.
[149] Á. Díaz-Ramos,et al. α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations , 2012, Journal of biomedicine & biotechnology.
[150] A. Blom,et al. Enolase of Streptococcus pneumoniae Binds Human Complement Inhibitor C4b-Binding Protein and Contributes to Complement Evasion , 2012, The Journal of Immunology.
[151] A. Hakansson,et al. High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae , 2012, mBio.
[152] I. Korona-Głowniak,et al. Characteristics of Streptococcus pneumoniae Strains Colonizing Upper Respiratory Tract of Healthy Preschool Children in Poland , 2012, TheScientificWorldJournal.
[153] E. Varon. Epidemiology of Streptococcus pneumoniae. , 2012, Medecine et maladies infectieuses.
[154] J. Hermoso,et al. Pneumococcal surface proteins: when the whole is greater than the sum of its parts. , 2012, Molecular oral microbiology.
[155] C. Orihuela,et al. Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia , 2012, Experimental Gerontology.
[156] S. Bentley,et al. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. , 2012, Microbes and infection.
[157] A. D'Amour,et al. Estimating Rates of Carriage Acquisition and Clearance and Competitive Ability for Pneumococcal Serotypes in Kenya With a Markov Transition Model , 2012, Epidemiology.
[158] P. Andrew,et al. The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection , 2012, PLoS pathogens.
[159] A. Hakansson,et al. Pneumococcal Interactions with Epithelial Cells Are Crucial for Optimal Biofilm Formation and Colonization In Vitro and In Vivo , 2012, Infection and Immunity.
[160] L. McDaniel,et al. Nontypeable Pneumococci Can Be Divided into Multiple cps Types, Including One Type Expressing the Novel Gene pspK , 2012, mBio.
[161] Matthew R Moore,et al. Aging population and future burden of pneumococcal pneumonia in the United States. , 2012, The Journal of infectious diseases.
[162] K. Mulholland,et al. Serotype replacement after pneumococcal vaccination , 2012, The Lancet.
[163] P. Chavanet. Pneumococcus infections: is the burden still as heavy? , 2012, Medecine et maladies infectieuses.
[164] P. Rohani,et al. Influenza and community-acquired pneumonia interactions: the impact of order and time of infection on population patterns. , 2012, American journal of epidemiology.
[165] A. Tomasz,et al. Isolation and analysis of cell wall components from Streptococcus pneumoniae. , 2012, Analytical biochemistry.
[166] S. Normark,et al. LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent Peptidoglycan* , 2012, The Journal of Biological Chemistry.
[167] S. Hamada,et al. α-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps* , 2012, The Journal of Biological Chemistry.
[168] M. Nahm,et al. Issues and challenges in the development of pneumococcal protein vaccines , 2012, Expert review of vaccines.
[169] M. Nahm,et al. Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. , 2012, Aging and disease.
[170] Robin Patel,et al. The Role of IL-17 in the Association between Pneumococcal Pneumonia and Allergic Sensitization , 2011, International journal of microbiology.
[171] J. Woof,et al. Structure and function relationships in IgA , 2011, Mucosal Immunology.
[172] John S. Bradley,et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[173] K. Klugman,et al. The future of pneumococcal disease prevention. , 2011, Vaccine.
[174] Kimberly M. Davis,et al. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. , 2011, The Journal of clinical investigation.
[175] J. Yuste,et al. Nasopharyngeal Colonization and Invasive Disease Are Enhanced by the Cell Wall Hydrolases LytB and LytC of Streptococcus pneumoniae , 2011, PloS one.
[176] R. Klevens,et al. Manual for the surveillance of vaccine-preventable diseases. Chapter 3: Hepatitis A , 2011 .
[177] S. Hem,et al. Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response , 2011, Journal of immune based therapies and vaccines.
[178] W. Pomat,et al. Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance , 2011, Vaccine.
[179] J. Tschopp,et al. The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia , 2011, The Journal of Immunology.
[180] Diederik van de Beek,et al. Pathogenesis and Pathophysiology of Pneumococcal Meningitis , 2011, Clinical Microbiology Reviews.
[181] C. Donati,et al. The Streptococcus pneumoniae Pilus-1 Displays a Biphasic Expression Pattern , 2011, PloS one.
[182] S. Bencharit,et al. Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. , 2011, Omics : a journal of integrative biology.
[183] A. Camilli,et al. Streptococcus pneumoniae Is Desiccation Tolerant and Infectious upon Rehydration , 2011, mBio.
[184] A. Varvarigou,et al. Phagocytic ability of neutrophils and monocytes in neonates , 2011, BMC pediatrics.
[185] A. Reunanen,et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. , 2011, Vaccine.
[186] K. Ariyoshi,et al. Association Between Nasopharyngeal Load of Streptococcus pneumoniae, Viral Coinfection, and Radiologically Confirmed Pneumonia in Vietnamese Children , 2011, The Pediatric infectious disease journal.
[187] J. Tschopp,et al. Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4 , 2010, PLoS pathogens.
[188] David R. Riley,et al. Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species , 2010, Genome Biology.
[189] Justin S. Hogg,et al. Generation of Genic Diversity among Streptococcus pneumoniae Strains via Horizontal Gene Transfer during a Chronic Polyclonal Pediatric Infection , 2010, PLoS pathogens.
[190] C. Orihuela,et al. The Pneumococcal Serine-Rich Repeat Protein Is an Intra-Species Bacterial Adhesin That Promotes Bacterial Aggregation In Vivo and in Biofilms , 2010, PLoS pathogens.
[191] T. Mitchell,et al. Streptococcus pneumoniae: virulence factors and variation. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[192] J. García,et al. Insights into pneumococcal fratricide from the crystal structures of the modular killing factor LytC , 2010, Nature Structural &Molecular Biology.
[193] T. Poll,et al. Role of CD14 in Lung Inflammation and Infection , 2011, Intensive Care Medicine.
[194] D. Isaacman,et al. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[195] M. de Martino,et al. Realtime PCR Is More Sensitive than Multiplex PCR for Diagnosis and Serotyping in Children with Culture Negative Pneumococcal Invasive Disease , 2010, PloS one.
[196] Recommended immunization schedule for persons aged 7 through 18 years , 2010, AAP News.
[197] C. Whitney,et al. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). , 2010, MMWR. Morbidity and mortality weekly report.
[198] B. Yawn,et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. , 2010, The Journal of allergy and clinical immunology.
[199] W. Schaffner,et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.
[200] D. Morens,et al. Bacterial pathogens and death during the 1918 influenza pandemic. , 2009, The New England journal of medicine.
[201] Jeremy S. Brown,et al. The Streptococcuspneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms , 2009, Infection and Immunity.
[202] Antonio Anzueto,et al. Community-acquired pneumonia in elderly patients. , 2009, Aging health.
[203] S. Opal,et al. Pathogenesis, treatment, and prevention of pneumococcal pneumonia , 2009, The Lancet.
[204] P. Murray. Beyond peptidoglycan for Nod2 , 2009, Nature Immunology.
[205] C. Orihuela,et al. The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells , 2009, Molecular microbiology.
[206] M. Rohde,et al. Pneumococcal Interaction with Human Dendritic Cells: Phagocytosis, Survival, and Induced Adaptive Immune Response Are Manipulated by PavA1 , 2009, Journal of Immunology.
[207] G. Pawelec,et al. Mechanisms of immunosenescence , 2009, Immunity & Ageing.
[208] L. Turka,et al. The contribution of direct TLR signaling to T cell responses , 2009, Immunologic research.
[209] B. Best. Nuclear DNA damage as a direct cause of aging. , 2009, Rejuvenation research.
[210] V. Eldholm,et al. Fratricide in Streptococcus pneumoniae: contributions and role of the cell wall hydrolases CbpD, LytA and LytC. , 2009, Microbiology.
[211] S. Shelburne,et al. Inhaled therapeutics for prevention and treatment of pneumonia , 2009, Expert opinion on drug safety.
[212] A. Blom,et al. Clinical Isolates of Streptococcus pneumoniae Bind the Complement Inhibitor C4b-Binding Protein in a PspC Allele-Dependent Fashion1 , 2009, The Journal of Immunology.
[213] A. Martner,et al. Streptococcus pneumoniae Autolysis Prevents Phagocytosis and Production of Phagocyte-Activating Cytokines , 2009, Infection and Immunity.
[214] R. Dagan,et al. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. , 2009, Vaccine.
[215] Shan Lu. Heterologous prime-boost vaccination. , 2009, Current opinion in immunology.
[216] C. Bryant,et al. Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer , 2009, Pharmacological Reviews.
[217] R. Reinert. The antimicrobial resistance profile of Streptococcus pneumoniae. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[218] Shizuo Akira,et al. The roles of TLRs, RLRs and NLRs in pathogen recognition. , 2009, International immunology.
[219] A. Pollard,et al. Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines , 2009, Nature Reviews Immunology.
[220] N. Campillo,et al. Crystal structure of CbpF, a bifunctional choline‐binding protein and autolysis regulator from Streptococcus pneumoniae , 2009, EMBO reports.
[221] R. Lodha,et al. Factors determining the outcome of children hospitalized with severe pneumonia , 2009, BMC pediatrics.
[222] N. Warner,et al. Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.
[223] J. Bartlett,et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[224] Kimberly M. Davis,et al. Resistance to Mucosal Lysozyme Compensates for the Fitness Deficit of Peptidoglycan Modifications by Streptococcus pneumoniae , 2008, PLoS pathogens.
[225] S. Jeyaseelan,et al. Neutrophil Recruitment to the Lungs during Bacterial Pneumonia , 2008, Infection and Immunity.
[226] D. Musher,et al. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. , 2008, The Journal of infectious diseases.
[227] M. Boermeester,et al. Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[228] G. Dennis Shanks,et al. Deaths from Bacterial Pneumonia during 1918–19 Influenza Pandemic , 2008, Emerging infectious diseases.
[229] A. Martner,et al. Pneumolysin Released during Streptococcus pneumoniae Autolysis Is a Potent Activator of Intracellular Oxygen Radical Production in Neutrophils , 2008, Infection and Immunity.
[230] C. Donati,et al. A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells , 2008, Journal of bacteriology.
[231] Jeffrey N. Weiser,et al. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease , 2008, Nature Reviews Microbiology.
[232] D. Murdoch,et al. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[233] T. van der Poll,et al. Role played by Toll-like receptors 2 and 4 in lipoteichoic acid-induced lung inflammation and coagulation. , 2008, The Journal of infectious diseases.
[234] G. Rajam,et al. Pneumococcal Surface Adhesin A (PsaA): A Review , 2008 .
[235] P. Andrew,et al. The ability to utilize mucin affects the regulation of virulence gene expression in Streptococcus pneumoniae. , 2008, FEMS microbiology letters.
[236] 23-valent pneumococcal polysaccharide vaccine. WHO position paper. , 2008, Releve epidemiologique hebdomadaire.
[237] João André Carriço,et al. High Rates of Transmission of and Colonization by Streptococcus pneumoniae and Haemophilus influenzae within a Day Care Center Revealed in a Longitudinal Study , 2007, Journal of Clinical Microbiology.
[238] V. Kolb-Bachofen,et al. Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands , 2007, Clinical and Vaccine Immunology.
[239] S. Clarke,et al. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. , 2007, The Journal of infectious diseases.
[240] Nathan D. Wolfe,et al. Origins of major human infectious diseases , 2007, Nature.
[241] S. Normark,et al. Capsule and d‐alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps , 2007, Cellular microbiology.
[242] D. Aw,et al. Immunosenescence: emerging challenges for an ageing population , 2007, Immunology.
[243] T. van der Poll,et al. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. , 2007, American journal of respiratory and critical care medicine.
[244] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[245] Z. Cohen,et al. Effect of hydrogen peroxide production and the Fenton reaction on membrane composition of Streptococcus pneumoniae. , 2007, Biochimica et biophysica acta.
[246] N. Cohen,et al. Mucociliary clearance – a critical upper airway host defense mechanism and methods of assessment , 2007, Current opinion in allergy and clinical immunology.
[247] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[248] A. Nelson,et al. Capsule Enhances Pneumococcal Colonization by Limiting Mucus-Mediated Clearance , 2006, Infection and Immunity.
[249] Bernard Martin,et al. Induction of competence regulons as a general response to stress in gram-positive bacteria. , 2006, Annual review of microbiology.
[250] T. Mitchell,et al. The Contribution of PspC to Pneumococcal Virulence Varies between Strains and Is Accomplished by Both Complement Evasion and Complement-Independent Mechanisms , 2006, Infection and Immunity.
[251] W. Vollmer,et al. A Functional dlt Operon, Encoding Proteins Required for Incorporation of d-Alanine in Teichoic Acids in Gram-Positive Bacteria, Confers Resistance to Cationic Antimicrobial Peptides in Streptococcus pneumoniae , 2006, Journal of bacteriology.
[252] M. Rohde,et al. Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. , 2006, Microbiology.
[253] L. Marraffini,et al. Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria , 2006, Microbiology and Molecular Biology Reviews.
[254] R. Rappuoli,et al. A pneumococcal pilus influences virulence and host inflammatory responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[255] T. Mitchell,et al. Innate immunity and the pneumococcus. , 2006, Microbiology.
[256] C. Dowson,et al. Distribution and Genetic Diversity of the ABC Transporter Lipoproteins PiuA and PiaA within Streptococcus pneumoniae and Related Streptococci , 2006, Journal of bacteriology.
[257] S. Hammerschmidt,et al. Versatility of pneumococcal surface proteins. , 2006, Microbiology.
[258] S. Clarke,et al. Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin , 2006, Journal of Clinical Microbiology.
[259] D. Golenbock,et al. The Apoptotic Response to Pneumolysin Is Toll-Like Receptor 4 Dependent and Protects against Pneumococcal Disease , 2005, Infection and Immunity.
[260] K. Cartwright,et al. Diagnosis of Invasive Pneumococcal Infection by Serotype-Specific Urinary Antigen Detection , 2005, Journal of Clinical Microbiology.
[261] D. Isaacman,et al. Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention , 2005, Pharmacotherapy.
[262] D. Tamandl,et al. Monocyte Toll-Like Receptor 4 Expression and LPS-Induced Cytokine Production Increase during Gestational Aging , 2005, Pediatric Research.
[263] Jos Boekhorst,et al. Genome-Wide Detection and Analysis of Cell Wall-Bound Proteins with LPxTG-Like Sorting Motifs , 2005, Journal of bacteriology.
[264] T. Mitchell,et al. Innate Immune Defense against Pneumococcal Pneumonia Requires Pulmonary Complement Component C3 , 2005, Infection and Immunity.
[265] Sébastien Guiral,et al. Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[266] P. Godowski. A smooth operator for LPS responses , 2005, Nature Immunology.
[267] H. Leaf,et al. Pneumococcal vaccination in adults , 2005, Current infectious disease reports.
[268] M. Lipsitch,et al. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[269] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[270] D. Musher,et al. Pneumococcal virulence factors and host immune responses to them , 1995, European Journal of Clinical Microbiology and Infectious Diseases.
[271] C. Dowson,et al. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia. , 2005, FEMS immunology and medical microbiology.
[272] P. Andrew,et al. The role of pneumolysin in pneumococcal pneumonia and meningitis , 2004, Clinical and experimental immunology.
[273] D. Briles,et al. Lipoprotein PsaA in Virulence of Streptococcus pneumoniae: Surface Accessibility and Role in Protection from Superoxide , 2004, Infection and Immunity.
[274] A. Devitt,et al. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? , 2004, Immunology.
[275] D. Briles,et al. PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin , 2004, Infection and Immunity.
[276] L. McDaniel,et al. Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H1 , 2004, The Journal of Immunology.
[277] Ulrich Dobrindt,et al. Genomic islands in pathogenic and environmental microorganisms , 2004, Nature Reviews Microbiology.
[278] G. Pozzi,et al. Pneumococcal Surface Protein C Contributes to Sepsis Caused by Streptococcus pneumoniae in Mice , 2004, Infection and Immunity.
[279] Manfred Rohde,et al. Glyceraldehyde-3-Phosphate Dehydrogenase of Streptococcus pneumoniae Is a Surface-Displayed Plasminogen-Binding Protein , 2004, Infection and Immunity.
[280] P. Andrew,et al. The innate immune response to pneumococcal lung infection: the untold story. , 2004, Trends in immunology.
[281] R. de Groot,et al. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. , 2004, The Lancet. Infectious diseases.
[282] David L Woodland,et al. Jump-starting the immune system: prime-boosting comes of age. , 2004, Trends in immunology.
[283] Herbert Schmidt,et al. Pathogenicity Islands in Bacterial Pathogenesis , 2004, Clinical Microbiology Reviews.
[284] J. Weiser,et al. Factors Contributing to Hydrogen Peroxide Resistance in Streptococcus pneumoniae Include Pyruvate Oxidase (SpxB) and Avoidance of the Toxic Effects of the Fenton Reaction , 2003, Journal of bacteriology.
[285] A. Tomasz,et al. Inactivation of the srtA Gene Affects Localization of Surface Proteins and Decreases Adhesion of Streptococcus pneumoniae to Human Pharyngeal Cells In Vitro , 2003, Infection and Immunity.
[286] J. Weiser,et al. Antibody-enhanced pneumococcal adherence requires IgA1 protease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[287] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[288] S. S. Tai,et al. A solute binding protein of Streptococcus pneumoniae iron transport. , 2003, FEMS microbiology letters.
[289] G. G. Hardy,et al. Genetic Alteration of Capsule Type but Not PspA Type Affects Accessibility of Surface-Bound Complement and Surface Antigens of Streptococcus pneumoniae , 2003, Infection and Immunity.
[290] M. Walport,et al. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[291] R. Donlan,et al. Biofilms: Microbial Life on Surfaces , 2002, Emerging infectious diseases.
[292] Jeremy S. Brown,et al. Characterization of Pit, a Streptococcus pneumoniae Iron Uptake ABC Transporter , 2002, Infection and Immunity.
[293] G. Pozzi,et al. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. , 2002, Gene.
[294] Jeremy S. Brown,et al. Immunization with Components of Two Iron Uptake ABC Transporters Protects Mice against Systemic Streptococcus pneumoniae Infection , 2001, Infection and Immunity.
[295] M. J. Jedrzejas. Pneumococcal Virulence Factors: Structure and Function , 2001, Microbiology and Molecular Biology Reviews.
[296] Jeremy S. Brown,et al. A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence , 2001, Molecular microbiology.
[297] M. Fine,et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.
[298] E. Tuomanen,et al. Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae , 2000, Infection and Immunity.
[299] J. Weiser,et al. Inhibitory and Bactericidal Effects of Hydrogen Peroxide Production by Streptococcus pneumoniae on Other Inhabitants of the Upper Respiratory Tract , 2000, Infection and Immunity.
[300] S. Hammerschmidt,et al. Species‐specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif , 2000, Molecular microbiology.
[301] K. Tryggvason,et al. The macrophage receptor MARCO. , 2000, Microbes and infection.
[302] S. Romagnani. Th1/Th2 cells. , 1999, Inflammatory bowel diseases.
[303] D. Briles,et al. Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae , 1999, Infection and Immunity.
[304] S. Hammerschmidt,et al. Identification of Pneumococcal Surface Protein A as a Lactoferrin-Binding Protein of Streptococcus pneumoniae , 1999, Infection and Immunity.
[305] M. González,et al. LytB, a novel pneumococcal murein hydrolase essential for cell separation , 1999, Molecular microbiology.
[306] S. Hammerschmidt,et al. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. , 1999, Infection and immunity.
[307] J. Rubins,et al. Pneumolysin: a multifunctional pneumococcal virulence factor. , 1998, The Journal of laboratory and clinical medicine.
[308] C. Rosenow,et al. Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae , 1997, Molecular microbiology.
[309] J. Claverys,et al. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases , 1997, Molecular microbiology.
[310] L. Brammer,et al. Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[311] J. P. Davis,et al. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[312] A. Wanner,et al. Mucociliary clearance in the airways. , 1996, American journal of respiratory and critical care medicine.
[313] J. Paton,et al. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae , 1996, Infection and immunity.
[314] P. Andrew,et al. Thiol‐activated cytolysins , 1996 .
[315] J. Paton,et al. Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. , 1996, Microbial pathogenesis.
[316] O. Massidda,et al. Bacterial walls, peptidoglycan hydrolases, autolysins, and autolysis. , 1996, Microbial drug resistance.
[317] J. Verhoef,et al. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines , 1995 .
[318] J. Verhoef,et al. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines , 1995, Microbiological reviews.
[319] H. Masure,et al. Peptide permeases from Streptococcus pneumoniae affect adherence to eucaryotic cells , 1995, Infection and immunity.
[320] H. Masure,et al. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization , 1994, Infection and immunity.
[321] S. S. Tai,et al. Hemin utilization is related to virulence of Streptococcus pneumoniae , 1993, Infection and immunity.
[322] R. Breiman,et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.
[323] Grossman Rf,et al. Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. , 1993 .
[324] G. Pugliese,et al. Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.
[325] P. Andrew,et al. Molecular Analysis of The Pathogenicity of Streptococcus Pneumoniae: The Role of Pneumococcal Proteins , 1993 .
[326] J. Granton,et al. Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment. , 1993, Clinics in chest medicine.
[327] A. Denman. Cellular and Molecular Immunology , 1992 .
[328] J. Quinn. Mechanisms of Resistance to β-Lactam Antibiotics , 1991 .
[329] M. Proctor,et al. Production of immunoglobulin A protease by Streptococcus pneumoniae from animals , 1990 .
[330] R. Macgregor,et al. Neutrophil function in healthy elderly subjects. , 1990, Journal of gerontology.
[331] P W Andrew,et al. Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity , 1989, Infection and immunity.
[332] B. Gray,et al. Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life. , 1988, The Journal of infectious diseases.
[333] L. Grossman,et al. Clinical, laboratory, and radiological information in the diagnosis of pneumonia in children. , 1988, Annals of emergency medicine.
[334] J. Falloon,et al. Neutrophil granules in health and disease. , 1986, The Journal of allergy and clinical immunology.
[335] J. Shelhamer,et al. Human respiratory mucous glycoproteins. , 1984, Experimental lung research.
[336] J. Paton,et al. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae , 1983, Infection and immunity.
[337] E. García,et al. [Bacterial autolysins]. , 1983, Microbiologia espanola.
[338] B. Gray,et al. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.
[339] E. Vallota,et al. Serum Complement Levels in Infancy: Age Related Changes , 1979, Pediatric Research.
[340] M. Hilleman,et al. Protective efficacy of pneumococcal polysaccharide vaccines. , 1977, JAMA.
[341] A. Tomasz. THE ROLE OF AUTOLYSINS IN CELL DEATH * , 1974, Annals of the New York Academy of Sciences.
[342] C. Forsberg,et al. Role of Autolysins in the Killing of Bacteria by Some Bactericidal Antibiotics , 1971, Journal of bacteriology.
[343] E. S. Robinson,et al. The Biology of Pneumococcus; the Bacteriological, Biochemical, and Immunological Characters and Activities of Diplococcus Pneumoniae , 1938 .
[344] T. Azarian,et al. Pneumococcal protein antigen serology varies with age and may predict antigenic 1 profile of colonizing isolates 2 3 , 2022 .
[345] Innate Immunity : The First Lines of Defense 2 , 2022 .